Literature DB >> 9033662

Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)hydroxyphenyl]-2-naphtalene carboxylic acid (CD437).

N Oridate1, M Higuchi, S Suzuki, B Shroot, W K Hong, R Lotan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9033662     DOI: 10.1002/(sici)1097-0215(19970207)70:4<484::aid-ijc21>3.0.co;2-e

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  5 in total

1.  Molecular recognition and enhancement of aqueous solubility and bioactivity of CD437 by β-cyclodextrin.

Authors:  Robert J Mishur; Matthew E Griffin; Cooper H Battle; Bin Shan; Janarthanan Jayawickramarajah
Journal:  Bioorg Med Chem Lett       Date:  2010-11-21       Impact factor: 2.823

Review 2.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

3.  Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis.

Authors:  Yolanda Bayon; Maria A Ortiz; Francisco J Lopez-Hernandez; Feng Gao; Michael Karin; Magnus Pfahl; F Javier Piedrafita
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

4.  Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines.

Authors:  Y Li; B Lin; A Agadir; R Liu; M I Dawson; J C Reed; J A Fontana; F Bost; P D Hobbs; Y Zheng; G Q Chen; B Shroot; D Mercola; X K Zhang
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

5.  An antagonist of retinoic acid receptors more effectively inhibits growth of human prostate cancer cells than normal prostate epithelium.

Authors:  R G Keedwell; Y Zhao; L A Hammond; K Wen; S Qin; L I Atangan; D-L Shurland; D M A Wallace; R Bird; A Reitmair; R A S Chandraratna; G Brown
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.